Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric HIV-1 Treatment Optimization (NVP-Exposed Infants)
NCT00427297Phase 3Terminated
- Sponsor
- University of Washington
- Start
- Sep 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of nevirapine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by University of Washington. Started Sep 2007; status: terminated.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00427297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00427297.